PCP HCV Treatment Training

Treating Hepatitis C in a Primary Care Setting

Who Should Attend
This program is directed to primary care physicians, specialists (ID, Gastro, Hepatology), nurses, public health, Drug and Alcohol counselors, care coordinators, advocates and other allied health care workers involved in the healthcare of patients who have risk factors for Hepatitis C particularly people who inject drugs.

Program Overview
The goal of this course module is to help clinicians and other service providers understand the local and regional picture of viral hepatitis, understand HCV screening recommendations, current treatment options, the diagnosis, how to treat hcv patients, and specific issues with vulnerable populations especially people who inject drugs, the opioid use disorder.

Learning Objectives
At course completion, attendees should be able to:

Performance
Increase HCV testing, diagnosis, counseling and treatment.

Competency
Successful linkage to HCV care will increase. Providers will understand how to diagnose and treat HCV.

Increase Knowledge
Understand the effectiveness and efficacy of HCV treatment for patients and the community.

Faculty Listing

Alison Kost, RN
Program Director
Community Liver Alliance

Divya Venkat, MD
Center for Inclusion Health
Allegheny Health Network

​Gina D’Aiello, PA-C
Physician Assistant, Clinical Educator

​Rebecca Altman, MPH, CRNP, FNP-BC, WHNP-BC, AAHIVM

Suzanna Masartis
CEO
Community Liver Alliance

PCP HCV Treatment Training

Treating Hepatitis C in a Primary Care Setting

Who Should Attend
This program is directed to primary care physicians, specialists (ID, Gastro, Hepatology), nurses, public health, Drug and Alcohol counselors, care coordinators, advocates and other allied health care workers involved in the healthcare of patients who have risk factors for Hepatitis C particularly people who inject drugs.

Program Overview
The goal of this course module is to help clinicians and other service providers understand the local and regional picture of viral hepatitis, understand HCV screening recommendations, current treatment options, the diagnosis, how to treat hcv patients, and specific issues with vulnerable populations especially people who inject drugs, the opioid use disorder.

Learning Objectives
At course completion, attendees should be able to:

Performance
Increase HCV testing, diagnosis, counseling and treatment.

Competency
Successful linkage to HCV care will increase. Providers will understand how to diagnose and treat HCV.

Increase Knowledge
Understand the effectiveness and efficacy of HCV treatment for patients and the community.

Faculty Listing

Alison Kost, RN
Program Director
Community Liver Alliance

Divya Venkat, MD
Center for Inclusion Health
Allegheny Health Network

​Gina D’Aiello, PA-C
Physician Assistant, Clinical Educator

​Rebecca Altman, MPH, CRNP, FNP-BC, WHNP-BC, AAHIVM

Suzanna Masartis
CEO
Community Liver Alliance

PCP HCV Treatment Training

Treating Hepatitis C in a Primary Care Setting

Who Should Attend
This program is directed to primary care physicians, specialists (ID, Gastro, Hepatology), nurses, public health, Drug and Alcohol counselors, care coordinators, advocates and other allied health care workers involved in the healthcare of patients who have risk factors for Hepatitis C particularly people who inject drugs.

Program Overview
The goal of this course module is to help clinicians and other service providers understand the local and regional picture of viral hepatitis, understand HCV screening recommendations, current treatment options, the diagnosis, how to treat hcv patients, and specific issues with vulnerable populations especially people who inject drugs, the opioid use disorder.

Learning Objectives
At course completion, attendees should be able to:

Performance
Increase HCV testing, diagnosis, counseling and treatment.

Competency
Successful linkage to HCV care will increase. Providers will understand how to diagnose and treat HCV.

Increase Knowledge
Understand the effectiveness and efficacy of HCV treatment for patients and the community.

Faculty Listing

Alison Kost, RN
Program Director
Community Liver Alliance

Divya Venkat, MD
Center for Inclusion Health
Allegheny Health Network

​Gina D’Aiello, PA-C
Physician Assistant, Clinical Educator

​Rebecca Altman, MPH, CRNP, FNP-BC, WHNP-BC, AAHIVM

Suzanna Masartis
CEO
Community Liver Alliance

aca6c09733a2bbb979f3b12695d177a6

Treating Hepatitis C in a Primary Care Setting CME Provider Virtual Training Program

Program Overview
The goal of this course module is to help clinicians and other service providers understand the local and regional picture of HCV, understand HCV screening recommendations, current treatment options, the diagnosis, how to treat HCV patients, and specific issues with vulnerable populations especially people who use drugs and as it relates to the opioid use disorder epidemic.
Who Should Attend
This program is directed to primary care physicians, specialists (Infectious Disease, Gastroenterology, Hepatology), advanced practice provides, nurses, public health professionals, drug and alcohol counselors, care coordinators, advocates and other allied health care workers involved in the healthcare of patients who have risk factors for Viral Hepatitis C (HCV) particularly people who use drugs.
Learning Objectives
At course completion, attendees should be able to:
Performance
Increase HCV testing, diagnosis, counseling and treatment.
Competency
Successful linkage to HCV care will increase. Providers will understand how to diagnose and treat HCV.
Increase Knowledge
Understand the effectiveness and efficacy of HCV treatment for patients and the community.
Curriculum:
• Statistics and disease burden
• Disease progression
• Extrahepatic manifestations associated with HCV
• Barriers faced by patients
• Advantages of treating in a primary care setting
• Pre-treatment assessment and evaluation
• Choosing appropriate treatment
• Preparing for treatment
• Prior authorization
• Monitoring treatment/Post-treatment monitoring
• Managing advanced and complicated disease
• Understanding drug interactions
• HBV reactivation
• Case Studies
• When to refer to specialist
• Preventing reinfection
• COVID-19 and HCV
• Understanding the role of Specialty Pharmacy/340B Specialty Pharmacy
Support:
• Participant Treatment Toolkit and resources
• Phone consultation and backup for complex cases
• Specialist referral
• Continuing education
Provider Commitment:
• Trained sites commit to sharing treatment data on a quarterly basis for 1 year via the Community Liver Alliance treatment data log.
For more information and to schedule a training program contact the Community Liver Alliance. 412-501-3CLA or Suzanna@communityliveralliance.org
Virtual

CLA Post AASLD Conference

Program Overview

The goal of the CME program is to learn more about current trends, management techniques, recent innovations, and research to treat a full range of liver conditions, including Fatty Liver/NASH, Hepatocellular Carcinoma, Cholestatic Diseases, and Liver Transplantation. The American Association for the Study of Liver Diseases (AASLD) is the leading organization of scientists and healthcare professionals committed to preventing and curing liver disease. The AASLD fosters research that leads to improved treatment options for millions of liver disease patients. They advance the science and practice of hepatology through educational conferences, training programs, professional publications, and partnerships with government agencies and sister societies. Each November, the AASLD holds the Annual Liver Meeting to provide access and education to groundbreaking science, the exchange of ideas with leading clinicians and researchers, and network with peers.

Who Should Attend?

This course is designed for providers in hepatology, gastroenterology, and abdominal and general surgery, referring primary care physicians, and other health care professionals with an interest in the treatment and latest research for liver disease.

Learning Objectives

At course completion, attendees should be able to:

  • Identify advancements in non-alcoholic and alcoholic liver disease treatments, with attention to liver diseases such as NAFLD, cholestatic diseases, hepatocellular carcinoma, and viral hepatitis.

  • Address barriers to liver transplantation and living-donor liver transplant, leading to enhanced patient care.

  • Foster the development of multidisciplinary and interactive models to treat liver diseases.

  • Partner with other regional academic liver programs and regional nonprofit collaborators to educate the regional medical community about liver disease advancements.


REGISTRATION IS FREE FOR PROVIDERS, STUDENTS, PATIENTS AND CAREGIVERS


CME Accreditation and Designation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint provider ship of Excela Health and the Community Liver Alliance. Excela Health is accredited by the ACCME to provide continuing medical education for physicians.

Excela Health designates this live activity for a maximum of 3.0 AMA PRA Category Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Other health care professionals are awarded 0.3 continuing education units (CEU’s) which are equal to 3 contact hours.

Faculty Disclosure

All individuals in a position to control the content of this education activity including members of the planning committee, speakers, presenters, authors, and/or content reviewers have disclosed all relevant financial relationships with any entity producing, marketing, re-selling, or distributing health care goods or services, used on, or consumed by, patients.

Acknowledgement of Commercial Support

We gratefully acknowledge Virtual Exhibitors support from the following to support this activity:

Download the conference brochure

aca6c09733a2bbb979f3b12695d177a6

Treating Hepatitis C in a Primary Care Setting CME Provider Virtual Training Program

Program Overview
The goal of this course module is to help clinicians and other service providers understand the local and regional picture of HCV, understand HCV screening recommendations, current treatment options, the diagnosis, how to treat HCV patients, and specific issues with vulnerable populations especially people who use drugs and as it relates to the opioid use disorder epidemic.
Who Should Attend
This program is directed to primary care physicians, specialists (Infectious Disease, Gastroenterology, Hepatology), advanced practice provides, nurses, public health professionals, drug and alcohol counselors, care coordinators, advocates and other allied health care workers involved in the healthcare of patients who have risk factors for Viral Hepatitis C (HCV) particularly people who use drugs.
Learning Objectives
At course completion, attendees should be able to:
Performance
Increase HCV testing, diagnosis, counseling and treatment.
Competency
Successful linkage to HCV care will increase. Providers will understand how to diagnose and treat HCV.
Increase Knowledge
Understand the effectiveness and efficacy of HCV treatment for patients and the community.
Curriculum:
• Statistics and disease burden
• Disease progression
• Extrahepatic manifestations associated with HCV
• Barriers faced by patients
• Advantages of treating in a primary care setting
• Pre-treatment assessment and evaluation
• Choosing appropriate treatment
• Preparing for treatment
• Prior authorization
• Monitoring treatment/Post-treatment monitoring
• Managing advanced and complicated disease
• Understanding drug interactions
• HBV reactivation
• Case Studies
• When to refer to specialist
• Preventing reinfection
• COVID-19 and HCV
• Understanding the role of Specialty Pharmacy/340B Specialty Pharmacy
Support:
• Participant Treatment Toolkit and resources
• Phone consultation and backup for complex cases
• Specialist referral
• Continuing education
Provider Commitment:
• Trained sites commit to sharing treatment data on a quarterly basis for 1 year via the Community Liver Alliance treatment data log.
For more information and to schedule a training program contact the Community Liver Alliance. 412-501-3CLA or Suzanna@communityliveralliance.org
aca6c09733a2bbb979f3b12695d177a6

Treating Hepatitis C in a Primary Care Setting CME Provider Virtual Training Program

Program Overview
The goal of this course module is to help clinicians and other service providers understand the local and regional picture of HCV, understand HCV screening recommendations, current treatment options, the diagnosis, how to treat HCV patients, and specific issues with vulnerable populations especially people who use drugs and as it relates to the opioid use disorder epidemic.
Who Should Attend
This program is directed to primary care physicians, specialists (Infectious Disease, Gastroenterology, Hepatology), advanced practice provides, nurses, public health professionals, drug and alcohol counselors, care coordinators, advocates and other allied health care workers involved in the healthcare of patients who have risk factors for Viral Hepatitis C (HCV) particularly people who use drugs.
Learning Objectives
At course completion, attendees should be able to:
Performance
Increase HCV testing, diagnosis, counseling and treatment.
Competency
Successful linkage to HCV care will increase. Providers will understand how to diagnose and treat HCV.
Increase Knowledge
Understand the effectiveness and efficacy of HCV treatment for patients and the community.
Curriculum:
• Statistics and disease burden
• Disease progression
• Extrahepatic manifestations associated with HCV
• Barriers faced by patients
• Advantages of treating in a primary care setting
• Pre-treatment assessment and evaluation
• Choosing appropriate treatment
• Preparing for treatment
• Prior authorization
• Monitoring treatment/Post-treatment monitoring
• Managing advanced and complicated disease
• Understanding drug interactions
• HBV reactivation
• Case Studies
• When to refer to specialist
• Preventing reinfection
• COVID-19 and HCV
• Understanding the role of Specialty Pharmacy/340B Specialty Pharmacy
Support:
• Participant Treatment Toolkit and resources
• Phone consultation and backup for complex cases
• Specialist referral
• Continuing education
Provider Commitment:
• Trained sites commit to sharing treatment data on a quarterly basis for 1 year via the Community Liver Alliance treatment data log.
For more information and to schedule a training program contact the Community Liver Alliance. 412-501-3CLA or Suzanna@communityliveralliance.org
aca6c09733a2bbb979f3b12695d177a6

Treating Hepatitis C in a Primary Care Setting CME Provider Virtual Training Program

Program Overview
The goal of this course module is to help clinicians and other service providers understand the local and regional picture of HCV, understand HCV screening recommendations, current treatment options, the diagnosis, how to treat HCV patients, and specific issues with vulnerable populations especially people who use drugs and as it relates to the opioid use disorder epidemic.
Who Should Attend
This program is directed to primary care physicians, specialists (Infectious Disease, Gastroenterology, Hepatology), advanced practice provides, nurses, public health professionals, drug and alcohol counselors, care coordinators, advocates and other allied health care workers involved in the healthcare of patients who have risk factors for Viral Hepatitis C (HCV) particularly people who use drugs.
Learning Objectives
At course completion, attendees should be able to:
Performance
Increase HCV testing, diagnosis, counseling and treatment.
Competency
Successful linkage to HCV care will increase. Providers will understand how to diagnose and treat HCV.
Increase Knowledge
Understand the effectiveness and efficacy of HCV treatment for patients and the community.
Curriculum:
• Statistics and disease burden
• Disease progression
• Extrahepatic manifestations associated with HCV
• Barriers faced by patients
• Advantages of treating in a primary care setting
• Pre-treatment assessment and evaluation
• Choosing appropriate treatment
• Preparing for treatment
• Prior authorization
• Monitoring treatment/Post-treatment monitoring
• Managing advanced and complicated disease
• Understanding drug interactions
• HBV reactivation
• Case Studies
• When to refer to specialist
• Preventing reinfection
• COVID-19 and HCV
• Understanding the role of Specialty Pharmacy/340B Specialty Pharmacy
Support:
• Participant Treatment Toolkit and resources
• Phone consultation and backup for complex cases
• Specialist referral
• Continuing education
Provider Commitment:
• Trained sites commit to sharing treatment data on a quarterly basis for 1 year via the Community Liver Alliance treatment data log.
For more information and to schedule a training program contact the Community Liver Alliance. 412-501-3CLA or Suzanna@communityliveralliance.org
aca6c09733a2bbb979f3b12695d177a6

Treating Hepatitis C in a Primary Care Setting CME Provider Virtual Training Program

Program Overview
The goal of this course module is to help clinicians and other service providers understand the local and regional picture of HCV, understand HCV screening recommendations, current treatment options, the diagnosis, how to treat HCV patients, and specific issues with vulnerable populations especially people who use drugs and as it relates to the opioid use disorder epidemic.
Who Should Attend
This program is directed to primary care physicians, specialists (Infectious Disease, Gastroenterology, Hepatology), advanced practice provides, nurses, public health professionals, drug and alcohol counselors, care coordinators, advocates and other allied health care workers involved in the healthcare of patients who have risk factors for Viral Hepatitis C (HCV) particularly people who use drugs.
Learning Objectives
At course completion, attendees should be able to:
Performance
Increase HCV testing, diagnosis, counseling and treatment.
Competency
Successful linkage to HCV care will increase. Providers will understand how to diagnose and treat HCV.
Increase Knowledge
Understand the effectiveness and efficacy of HCV treatment for patients and the community.
Curriculum:
• Statistics and disease burden
• Disease progression
• Extrahepatic manifestations associated with HCV
• Barriers faced by patients
• Advantages of treating in a primary care setting
• Pre-treatment assessment and evaluation
• Choosing appropriate treatment
• Preparing for treatment
• Prior authorization
• Monitoring treatment/Post-treatment monitoring
• Managing advanced and complicated disease
• Understanding drug interactions
• HBV reactivation
• Case Studies
• When to refer to specialist
• Preventing reinfection
• COVID-19 and HCV
• Understanding the role of Specialty Pharmacy/340B Specialty Pharmacy
Support:
• Participant Treatment Toolkit and resources
• Phone consultation and backup for complex cases
• Specialist referral
• Continuing education
Provider Commitment:
• Trained sites commit to sharing treatment data on a quarterly basis for 1 year via the Community Liver Alliance treatment data log.
For more information and to schedule a training program contact the Community Liver Alliance. 412-501-3CLA or Suzanna@communityliveralliance.org
aca6c09733a2bbb979f3b12695d177a6

Treating Hepatitis C in a Primary Care Setting CME Provider Virtual Training Program

Program Overview
The goal of this course module is to help clinicians and other service providers understand the local and regional picture of HCV, understand HCV screening recommendations, current treatment options, the diagnosis, how to treat HCV patients, and specific issues with vulnerable populations especially people who use drugs and as it relates to the opioid use disorder epidemic.
Who Should Attend
This program is directed to primary care physicians, specialists (Infectious Disease, Gastroenterology, Hepatology), advanced practice provides, nurses, public health professionals, drug and alcohol counselors, care coordinators, advocates and other allied health care workers involved in the healthcare of patients who have risk factors for Viral Hepatitis C (HCV) particularly people who use drugs.
Learning Objectives
At course completion, attendees should be able to:
Performance
Increase HCV testing, diagnosis, counseling and treatment.
Competency
Successful linkage to HCV care will increase. Providers will understand how to diagnose and treat HCV.
Increase Knowledge
Understand the effectiveness and efficacy of HCV treatment for patients and the community.
Curriculum:
• Statistics and disease burden
• Disease progression
• Extrahepatic manifestations associated with HCV
• Barriers faced by patients
• Advantages of treating in a primary care setting
• Pre-treatment assessment and evaluation
• Choosing appropriate treatment
• Preparing for treatment
• Prior authorization
• Monitoring treatment/Post-treatment monitoring
• Managing advanced and complicated disease
• Understanding drug interactions
• HBV reactivation
• Case Studies
• When to refer to specialist
• Preventing reinfection
• COVID-19 and HCV
• Understanding the role of Specialty Pharmacy/340B Specialty Pharmacy
Support:
• Participant Treatment Toolkit and resources
• Phone consultation and backup for complex cases
• Specialist referral
• Continuing education
Provider Commitment:
• Trained sites commit to sharing treatment data on a quarterly basis for 1 year via the Community Liver Alliance treatment data log.
For more information and to schedule a training program contact the Community Liver Alliance. 412-501-3CLA or Suzanna@communityliveralliance.org